Angelini Pharma said on Thursday it had completed the acquisition of U.S. rare-disease drug maker Catalyst Pharmaceuticals in a $4.1 billion deal involving Italian state lender CDP. The acquisition gives Angelini full...
Pharmaceutical
Natco Pharma completes acquisition of additional 13.25% stake in Adcock Ingram
Natco Pharma announced the successful completion of its acquisition of an additional 13.25% equity stake in Adcock Ingram Holdings Proprietary Limited (Adcock Ingram), a leading South African pharmaceutical and...
Emcure buys remaining 12.05% in Gennova to take full control
Emcure Pharma is taking full control of its biopharma subsidiary, Gennova Biopharmaceuticals, by buying out the remaining 12.05% stake held by Gennova’s chief executive Sanjay Singh and other shareholders. Pune...
Marksans Pharma to acquire Germany-based ABCnow GmbH
Marksans Pharma Ltd on Wednesday said it will acquire Germany-based pharmaceutical wholesale and distributor ABCnow GmbH for euro 8,92,384 (nearly Rs 10 crore). The company has entered into a definitive agreement to...
Kedaara may lead race to acquire stake in Olive PharmaScience
The deal may value Olive PharmaScience at around ₹4,500 crore. Kedaara Capital Investment Managers Ltd is likely to emerge as the frontrunner to acquire a minority stake in Olive PharmaScience Ltd in a deal that values...
Vertex to buy Crinetics for $10 billion in rare-diseases push
Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of about $10 billion, the companies said on Monday, adding treatments for rare hormonal diseases to its portfolio. Vertex’s offer...
Novartis to acquire UK-based Myricx Bio for up to $1.5 billion
Swiss drugmaker Novartis said on Monday it had agreed to pay up to $1.5 billion for U.K.-based biotechnology firm Myricx Bio in a deal expected to close in the second half of 2026. In a statement, Novartis said it...
Aurobindo Pharma receives FTC nod for $250 million acquisition of Lannett Company
Aurobindo Pharma announced that its wholly owned subsidiary, Aurobindo Pharma USA, Inc., has received approval from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC. The...
Sun Pharma to acquire 100% stake in Innovcare Lifesciences for Rs 271 crore
Sun Pharmaceutical Industries said that it has entered into an agreement to acquire 100% of the outstanding shares of Innovcare Lifesciences for a total consideration of Rs 271.2 crore. Innovcare Lifesciences is engaged...
AbbVie sharpens immunology focus with $10.9 billion Apogee deal
AbbVie said on Monday it would buy Apogee Therapeutics for $10.9 billion, the company’s largest buyout in more than five years, as it seeks to bolster its treatment pipeline for inflammatory diseases like atopic...
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transaction
Sun Pharmaceutical Industries Ltd will acquire Mumbai-based Innovcare Lifesciences Private Ltd for about $28.7 million (around Rs 271.2 crore) in an all-cash deal, as India’s largest drugmaker looks to strengthen...
Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett Company
Aurobindo Pharma’s US subsidiary received U.S. Federal Trade Commission (FTC) approval to proceed with the acquisition of Lannett Company LLC in a deal valued at $250 million, the company announced on Monday. The...
